Terms: = Kidney tumors AND IDH1, IDP, 3417, ENSG00000138413, IDH, PICD, O75874
24 results:
1. Aggressive renal cell carcinoma with biphasic papillary and solid clear cell features harboring idh2 (R172M) mutation.
Zhao M; Xia Y; Wang W
Pathol Res Pract; 2024 Jan; 253():155090. PubMed ID: 38181579
[TBL] [Abstract] [Full Text] [Related]
2. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
3. Occurrence of non-central nervous system cancers during postoperative follow-up of patients who underwent surgery for a WHO grade II glioma: implications for therapeutic management.
Duffau H
J Neurooncol; 2023 Mar; 162(1):237-244. PubMed ID: 36913047
[TBL] [Abstract] [Full Text] [Related]
4. An idh-independent mechanism of DNA hypermethylation upon VHL inactivation in cancer.
Artemov AV; Zhenilo S; Kaplun D; Starshin A; Sokolov A; Mazur AM; Szpotan J; Gawronski M; Modrzejewska M; Gackowski D; Prokhortchouk EB
Epigenetics; 2022 Aug; 17(8):894-905. PubMed ID: 34494499
[TBL] [Abstract] [Full Text] [Related]
5. The Intrinsically Disordered Proteins MLLT3 (AF9) and MLLT1 (ENL) - Multimodal Transcriptional Switches With Roles in Normal Hematopoiesis, MLL Fusion Leukemia, and kidney Cancer.
Kabra A; Bushweller J
J Mol Biol; 2022 Jan; 434(1):167117. PubMed ID: 34174329
[TBL] [Abstract] [Full Text] [Related]
6. A pan-cancer perspective analysis reveals the opposite prognostic significance of CD133 in lower grade glioma and papillary renal cell carcinoma.
Wang H; Wang X; Xu L; Zhang J; Cao H
Sci Prog; 2021; 104(2):368504211010938. PubMed ID: 33878963
[TBL] [Abstract] [Full Text] [Related]
7. Wild-type idh1 inhibits the tumor growth through degrading HIF-α in renal cell carcinoma.
Chen S; Wang Y; Xiong Y; Peng T; Lu M; Zhang L; Guo Z
Int J Biol Sci; 2021; 17(5):1250-1262. PubMed ID: 33867843
[TBL] [Abstract] [Full Text] [Related]
8. Glycolysis-Related Genes Serve as Potential Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma.
Zhang Y; Chen M; Liu M; Xu Y; Wu G
Oxid Med Cell Longev; 2021; 2021():6699808. PubMed ID: 33564363
[TBL] [Abstract] [Full Text] [Related]
9. idh-wildtype glioblastomas and grade III/IV idh-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT.
Röhrich M; Loktev A; Wefers AK; Altmann A; Paech D; Adeberg S; Windisch P; Hielscher T; Flechsig P; Floca R; Leitz D; Schuster JP; Huber PE; Debus J; von Deimling A; Lindner T; Haberkorn U
Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2569-2580. PubMed ID: 31388723
[TBL] [Abstract] [Full Text] [Related]
10. The cancer driver genes idh1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
11. Discovery and Optimization of Quinolinone Derivatives as Potent, Selective, and Orally Bioavailable Mutant Isocitrate Dehydrogenase 1 (midh1) Inhibitors.
Lin J; Lu W; Caravella JA; Campbell AM; Diebold RB; Ericsson A; Fritzen E; Gustafson GR; Lancia DR; Shelekhin T; Wang Z; Castro J; Clarke A; Gotur D; Josephine HR; Katz M; Diep H; Kershaw M; Yao L; Kauffman G; Hubbs SE; Luke GP; Toms AV; Wang L; Bair KW; Barr KJ; Dinsmore C; Walker D; Ashwell S
J Med Chem; 2019 Jul; 62(14):6575-6596. PubMed ID: 31199148
[TBL] [Abstract] [Full Text] [Related]
12. Role of polycyclic aromatic hydrocarbons as a co-factor in human papillomavirus-mediated carcinogenesis.
Zhang C; Luo Y; Zhong R; Law PTY; Boon SS; Chen Z; Wong CH; Chan PKS
BMC Cancer; 2019 Feb; 19(1):138. PubMed ID: 30744599
[TBL] [Abstract] [Full Text] [Related]
13. Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma.
Laba P; Wang J; Zhang J
BMC Cancer; 2018 Aug; 18(1):852. PubMed ID: 30153799
[TBL] [Abstract] [Full Text] [Related]
14. TET2 binds the androgen receptor and loss is associated with prostate cancer.
Nickerson ML; Das S; Im KM; Turan S; Berndt SI; Li H; Lou H; Brodie SA; Billaud JN; Zhang T; Bouk AJ; Butcher D; Wang Z; Sun L; Misner K; Tan W; Esnakula A; Esposito D; Huang WY; Hoover RN; Tucker MA; Keller JR; Boland J; Brown K; Anderson SK; Moore LE; Isaacs WB; Chanock SJ; Yeager M; Dean M; Andresson T
Oncogene; 2017 Apr; 36(15):2172-2183. PubMed ID: 27819678
[TBL] [Abstract] [Full Text] [Related]
15. Mitochondrial DNA copy number variation across human cancers.
Reznik E; Miller ML; Şenbabaoğlu Y; Riaz N; Sarungbam J; Tickoo SK; Al-Ahmadie HA; Lee W; Seshan VE; Hakimi AA; Sander C
Elife; 2016 Feb; 5():. PubMed ID: 26901439
[TBL] [Abstract] [Full Text] [Related]
16. Loss of 5-hydroxymethylcytosine is linked to gene body hypermethylation in kidney cancer.
Chen K; Zhang J; Guo Z; Ma Q; Xu Z; Zhou Y; Xu Z; Li Z; Liu Y; Ye X; Li X; Yuan B; Ke Y; He C; Zhou L; Liu J; Ci W
Cell Res; 2016 Jan; 26(1):103-18. PubMed ID: 26680004
[TBL] [Abstract] [Full Text] [Related]
17. Nuclear Receptor 4A1 (NR4A1) as a Drug Target for Renal Cell Adenocarcinoma.
Hedrick E; Lee SO; Kim G; Abdelrahim M; Jin UH; Safe S; Abudayyeh A
PLoS One; 2015; 10(6):e0128308. PubMed ID: 26035713
[TBL] [Abstract] [Full Text] [Related]
18. L-2-Hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancer.
Shim EH; Livi CB; Rakheja D; Tan J; Benson D; Parekh V; Kho EY; Ghosh AP; Kirkman R; Velu S; Dutta S; Chenna B; Rea SL; Mishur RJ; Li Q; Johnson-Pais TL; Guo L; Bae S; Wei S; Block K; Sudarshan S
Cancer Discov; 2014 Nov; 4(11):1290-8. PubMed ID: 25182153
[TBL] [Abstract] [Full Text] [Related]
19. Oncometabolites-driven tumorigenesis: From genetics to targeted therapy.
Morin A; Letouzé E; Gimenez-Roqueplo AP; Favier J
Int J Cancer; 2014 Nov; 135(10):2237-48. PubMed ID: 25124653
[TBL] [Abstract] [Full Text] [Related]
20. Reductive glutamine metabolism by idh1 mediates lipogenesis under hypoxia.
Metallo CM; Gameiro PA; Bell EL; Mattaini KR; Yang J; Hiller K; Jewell CM; Johnson ZR; Irvine DJ; Guarente L; Kelleher JK; Vander Heiden MG; Iliopoulos O; Stephanopoulos G
Nature; 2011 Nov; 481(7381):380-4. PubMed ID: 22101433
[TBL] [Abstract] [Full Text] [Related]
[Next]
